Products

Empagliflozin(Empagliflozin)

• Assess renal function before initiating empagliflozin and as clinically indicated. • The recommended dose of empagliflozin is 10 mg once daily, taken in the morning, with or without food....

Faxibet(Dapagliflozin)

Recommended Dosing  The recommended starting dose of Dapagliflozin is 5 mg once daily, taken in the morning, with or without food. In patients tolerating Dapagliflozin5 mg once daily who re...

Regonib(Regorafenib)

Recommended dose: 160 mg orally, once daily for the first 21 days of each 28-day cycle. -Take REGONIB after a low-fat meal.

Palbobrest(Palbociclib)

• Recommended starting dose: 125 mg once daily taken with food for 21 days followed by 7 days off treatment. • Dosing interruption and/or dose reductions are recommended based on individua...

(Ibrutinib) Lokemide

• MCL and MZL: 560 mg taken orally once daily. • CLL/SLL, WM, and cGVHD: 420 mg taken orally once daily.

Gefitinib (Gefitinib)

Patient Selection  Select patients for the first-line treatment of metastatic NSCLC with gefitinib based on the presence of EGFR exon 19 deletions or exon 21 L858R mutations in their tumor or pl...

Dasatinib (Dasanib)

• Dosage of Dasatinin in Adult Patients: -The recommended starting dosage of Dasatinib for chronic phase CML in adults is 100 mg  administered orally once daily.  -The recommended st...

Imatinib (Imatinib)

Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML): Oral: Chronic phase: 400 mg once daily; may be increased to 600 mg daily, if tolerated, for disease progression, lack of hem...

Kitent (Sunitinib)

GIST and Advanced RCC: •50 mg orally once daily, with or without food, 4 weeks on treatment followed by 2 weeks off. Adjuvant RCC: •50 mg orally once daily, with or without food, 4 we...

Kimotar (Erlotinib)

Treatment of locally advanced or metastatic non-small cell lung cancer 150 mg daily. Dosage reduction may be required for patients with hepatic impairment. Pancreatic Cancer, treatment of lo...

Kimonil(Nilotinib)

Recommended Adult Dose: Newly diagnosed Ph+ CML-CP: 300 mg orally twice daily. Resistant or intolerant Ph+ CML-CP and CML-AP: 400 mg orally twice daily. (2.1) Recommended Pediatric Dose: Newly Diagn...

Soranex(Sorafenib)

400 mg (2 tablets) orally twice daily without food. Treatment interruption and/or dose reduction may be needed to manage suspected adverse drug reactions

For Experts & healthcare professionals

How is technology impacting the quality assurance of our products

in our manufacturing sites many different types of technologies are being implemented to improve the processes of pharmaceutical manufacturing and Quality Assurance which ultimately, creates a safer medicine...

Our focus, high quality targeted medicines

At Kimia Pharmaceuticals, we are focused on medicine development in key cancer areas where there are patient needs. Our goal is to bring much needed new treatments to people with cancer.

Visit our scientific blogs ONCOMED

ASCO 2020 Gastrointestinal Cancers Symposium

Read breaking news and watch expert interviews from most recent american society of c...

2020 Genitourinary Cancers Symposium

Read breaking news and watch expert interviews from most recent american society of c...


ONCOGENE

Molecular Diagnostics in Colorectal Carcinoma

Watch related videos for expert opinions and download guidelines in OncoGene online m...

BCR-ABL mutations and CML treatment

BCR-ABL1 mutations that should NOT be treated with bosutinib, dasatinib or nilotinib ...

For patients & care givers

Patient Care

Cancer and its treatment can cause physical symptoms and side effects. They can also cause emotional, social, and financial burden. Managing these effects is called palliative care or supportive care.
Research shows that palliative care can improve the quality of patient’s life and help their feel more satisfied with the treatment that receive.
The quality of life of patient during treatment is one of the most important concerns we have. So, our patient care unit is ready to help patients and their families based on their needs.

Patient Care

About Us

drug's Factory

Company Infrastructure

drug export

Company Personnel

All together we are in constant  motion.                           
Cancer can not stop me & you ,Us !

 Kimia Pharmaceutical Co.